Listing will help Prudential expand
Article Abstract:
Prudential PLC's listing in the US will help the company expand its operations. The listing will enable Prudential to utilize its stock in order to purchase undervalued insurers in the US.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
AIG counterbid forces Prudential to change strategy
Article Abstract:
American International Group Inc. has made a counterbid to acquire American General Corp. for approximately $24.6 billion (27.4 billion euros). The counterbid forces Prudential PLC to seek an alternative plan.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Big size of Aegon share issue surprises market participants
Article Abstract:
Aegon NV launched a higher-than-expected share issue to raise capital for its acquisition of JC Penney Inc.'s direct-marketing operations. The share issue is valued at $1.5 billion (1.75 billion euros).
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Warning fails to dull Canal Plus: Share rise despite profit revision. Canal Plus posts net loss for '99 of 336 million euros
- Abstracts: Yahoo posts loss, lower revenue as sluggish ad market takes toll. Yahoo's earnings more than tripled in the 1st quarter
- Abstracts: GM's Opel veers off course; once hailed as `Mr. Fixit,' Chairman grapples with performance targets. DaimlerChrysler's net plunges as Chrysler, Freightliner slip
- Abstracts: On-Time Data of Region's Airlines Puts Them in the Front of the Class. Online travel agency prepares for takeoff, thanks to web pro
- Abstracts: Novartis angers critics in India: challenge of patent laws creates uproar among public-health advocates. Lawsuit is filed against Novartis on Ritalin sales